Critical Care Emergency Articles & Analysis
11 news found
Entegrion Announces CE Mark for Point of Care System for Blood Coagulation Monitoring. Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. ...
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions and community based health emergencies, announced today that the U.S. ...
Their responses included: Reducing IV restarts Less trauma to patients by reducing restart-related needlesticks Preserving patient veins for subsequent procedures Maintaining IV access in emergency and critical care situations, and when transporting patients Lowered costs due to less waste of IV supplies. ...
The US business serves a vital role, providing life and limb-saving medicines to healthcare professionals treating patients with critical conditions.” Thomas most recently served as Senior Vice President & General Manager for Medical Therapeutics at Endo Pharmaceuticals. ...
“This acquisition supports our strategy to build a portfolio of products that improves the standard of care for patients suffering from critical and rare conditions.” Xermelo will be commercially available from SERB outside the US and Japan starting in July 2022. ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, ...
BTG is a growing specialty pharmaceutical platform and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, supporting clinicians, healthcare systems and governments while ...
About SERB and BTG Specialty Pharmaceuticals Together, SERB and BTG are a growing specialty pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible, ...
Together, SERB and BTG are a fully integrated, global specialty pharmaceutical platform and a dedicated ally to healthcare providers treating patients with critical conditions. Backed by Charterhouse Capital Partners LLP, Partners Group, and Merieux Equity Partners, the firm has more than 400 employees in 11 offices, advanced manufacturing facilities, and a direct commercial ...
The proceeds will be used primarily to extend Abionic’s portfolio of Point-of-Care IVD tests for critical care and emergency medicine. Delivering on this strategy, Abionic is about to launch a multinational sepsis impact study of it’s Pancreatic Stone Protein (PSP) test for sepsis risk assessment and management, the ...
As a result of a growing research and development program, HORIBA Medical has recently developed two new products that aim to better meet the needs of today's clinical laboratories : The Yumizen H500 OT ‘Open Tube’ with flexible sampling to accommodate all sample types, particularly for rapid screening in critical care, emergency ...